Dr Nicolas Poirier , CEO, Ose Immunotherapeutics 00:00:00
OSE Immunotherapeutics (OSE) is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharmaceutical companies.